Mr. Kieran Smyth:

I will address Senator Dolan's point about determinants of health. One of the main advantages of a whole-of-government approach to Brexit is being able to deal with the full range of issues within that structure. From a health perspective, we are minded to ensure that the range of issues, including direct and indirect health issues, is taken into account in the Department of Foreign Affairs and Trade-led process.

Regarding determinants, it is important to focus on the issue of regulatory alignment. This will receive a great deal of attention in the next phase. I cannot say anything further on that at this point, but I thank the Senator for drawing out an important point concerning Brexit and health.